Pronova BioPharma Overview
- Founded
- 1837

- Status
- Acquired/Merged
- Employees
- 154

- Latest Deal Type
- M&A
- Financing Rounds
- 4
Pronova BioPharma General Information
Description
Developer lipid therapies. The company develops and manufactures marine originated omega-3 derived pharmaceutical products.
Contact Information
Website
Formerly Known As
Pronova Biocare
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
- Vollsveien 6
- 1366 Oslo
- Norway
+47 22 00 00 00
Pronova BioPharma Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Pronova BioPharma‘s full profile, request access.
Request a free trialPronova BioPharma Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Morten Jurs | Chief Executive Officer |
Pronova BioPharma Signals
Growth Rate

0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile

-35.5%.
530%
Size Multiple

219x
Median
Size Multiple
219x, 100th %ile

0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialPronova BioPharma Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Pronova BioPharma‘s full profile, request access.
Request a free trial